Patent · US Active

FGF21 mimetic antibodies and uses thereof

US11692046B2 · kind B2 · utility

0Cited by

6References

13Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Regis Cebe · Saint-Louis, FR
Stephane Olland · Arlington, US
David Langdon Yowe · North Quincy, US

Key dates

Filing date	Dec 18, 2020
Grant date	Jul 4, 2023
Priority date	—
Expiry date	Jul 12, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human β-klotho, and pharmaceutical compositions and methods of treatment comprising the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.